<!--

File produced by pipelineRunner package (for JATS 2 SCJATS with pipeline SCJATS)
At: 2025-05-22T15:12:27.89Z

Version        : 1.16.1
Last update    : 2024-08-27
Modified by    : dunnm

-->
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Database (Oxford)</journal-id><journal-id journal-id-type="iso-abbrev">Database (Oxford)</journal-id><journal-id journal-id-type="publisher-id">databa</journal-id><journal-title-group><journal-title>Database: The Journal of Biological Databases and Curation</journal-title></journal-title-group><issn pub-type="epub">1758-0463</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40315246</article-id><article-id pub-id-type="pmc">PMC12047452</article-id>
<article-id pub-id-type="doi">10.1093/database/baaf032</article-id><article-id pub-id-type="publisher-id">baaf032</article-id><article-categories><subj-group subj-group-type="heading"><subject>Database Tool</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/SCI00960</subject></subj-group></article-categories><title-group><article-title>STCDB4ND: a signal transduction classification database for neurological diseases</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gong</surname><given-names>Boyan</given-names></name><aff>
<institution content-type="department">Department of Bioinformatics, Institute of Biophysics, College of Life Sciences; Institute of Hematology, Zhejiang University School of Medicine, The First Affiliated Hospital, Zhejiang University</institution>, Hangzhou 310058, <country country="CN">China</country></aff></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Sida</given-names></name><aff>
<institution content-type="department">Department of Bioinformatics, Institute of Biophysics, College of Life Sciences; Institute of Hematology, Zhejiang University School of Medicine, The First Affiliated Hospital, Zhejiang University</institution>, Hangzhou 310058, <country country="CN">China</country></aff></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Yifan</given-names></name><aff>
<institution content-type="department">Department of Bioinformatics, Institute of Biophysics, College of Life Sciences; Institute of Hematology, Zhejiang University School of Medicine, The First Affiliated Hospital, Zhejiang University</institution>, Hangzhou 310058, <country country="CN">China</country></aff></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Liya</given-names></name><aff>
<institution content-type="department">Department of Bioinformatics, Institute of Biophysics, College of Life Sciences; Institute of Hematology, Zhejiang University School of Medicine, The First Affiliated Hospital, Zhejiang University</institution>, Hangzhou 310058, <country country="CN">China</country></aff></contrib><contrib contrib-type="author"><name><surname>Hofest&#x000e4;dt</surname><given-names>Ralf</given-names></name><aff>
<institution content-type="department">Department of Bioinformatics/Medical Informatics, Faculty of Technology, Bielefeld University</institution>, Bielefeld 33501, <country country="DE">Germany</country></aff></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9677-1699</contrib-id><name><surname>Chen</surname><given-names>Ming</given-names></name><!--mchen@zju.edu.cn--><aff>
<institution content-type="department">Department of Bioinformatics, Institute of Biophysics, College of Life Sciences; Institute of Hematology, Zhejiang University School of Medicine, The First Affiliated Hospital, Zhejiang University</institution>, Hangzhou 310058, <country country="CN">China</country></aff><aff>
<institution content-type="department">Zhejiang Key Laboratory of Multi-omics Precision Diagnosis and Treatment of Liver Diseases, Zhejiang University</institution>, Hangzhou 310058, <country country="CN">China</country></aff><xref rid="COR0001" ref-type="corresp"/></contrib></contrib-group><author-notes><corresp id="COR0001">*Corresponding author. Department of Bioinformatics, Institute of Biophysics, College of Life Sciences; Zhejiang Key Laboratory of Multi-omics Precision Diagnosis and Treatment of Liver Diseases; Zhejiang University, Hangzhou 310058, China. E-mail: <email xlink:href="mchen@zju.edu.cn">mchen@zju.edu.cn</email></corresp></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub" iso-8601-date="2025-05-02"><day>02</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>02</day><month>5</month><year>2025</year></pub-date><volume>2025</volume><elocation-id>baaf032</elocation-id><history><date date-type="received"><day>16</day><month>10</month><year>2024</year></date><date date-type="rev-recd"><day>14</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>02</day><month>4</month><year>2025</year></date><date date-type="editorial-decision"><day>29</day><month>3</month><year>2025</year></date><date date-type="corrected-typeset"><day>02</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025. Published by Oxford University Press.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="baaf032.pdf"/><abstract><title>Abstract</title><p>Neurological disorders pose significant global health challenges due to their complex etiology and insufficient understanding of underlying mechanisms. Signal transduction pathways are critical in the pathophysiology of these diseases and have been extensively studied to develop therapeutic interventions. However, existing databases for biological signal pathways often overlook the dynamic interactions between entities within these pathways and lack standardized representations of the signaling processes. To address these limitations, we present STCDB4ND, a specialized database focused on signal transduction pathways associated with neurological diseases. Utilizing the ST classification system, STCDB4ND provides a unified framework for pathway representation, emphasizing interactions and pathway characteristics. The database features advanced visualization tools, network analysis capabilities, and a key factor identification module, enabling researchers to comprehensively study these complex networks. Our analysis of neurological disease-related pathways using STCDB4ND revealed key signaling factors and supported existing findings on pathogenic mechanisms STCDB4ND serves as a valuable resource for advancing the understanding of neurological disease pathways and promoting novel therapeutic approaches. And we believe that STCDB will provide greater convenience for researchers in various fields as we expand the STCDB system&#x02019;s database in the future.</p><p>
<bold>Database URL</bold>: <ext-link xlink:href="https://bis.zju.edu.cn/STCDB" ext-link-type="uri">https://bis.zju.edu.cn/STCDB</ext-link></p></abstract><funding-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Zhejiang University</institution><institution-id institution-id-type="DOI">10.13039/501100004835</institution-id></institution-wrap>
</funding-source></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>SRTP Program of Zhejiang University</institution></institution-wrap>
</funding-source><award-id>Y202304085</award-id></award-group></funding-group><funding-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Zhejiang University</institution><institution-id institution-id-type="DOI">10.13039/501100004835</institution-id></institution-wrap>
</funding-source></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>SRTP Program of Zhejiang University</institution></institution-wrap>
</funding-source><award-id>Y202304085</award-id></award-group></funding-group><counts><page-count count="7"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Neurological disorders represent a global public health challenge, affecting individuals across all ages, cultures, and socioeconomic statuses. The complexity of these diseases makes them particularly difficult to study, and as a result, the causes and treatments for many remain not fully understood. In the existing research and treatment methods, cell signal transduction pathways have been confirmed to play an important role in the pathological study of neurological diseases [<xref rid="R1" ref-type="bibr">1</xref>]. Many drug design strategies target key nodes within these pathways, highlighting their immense research value. Given the intricate and interwoven nature of biological pathways, thorough analysis and research on these related networks can greatly aid in elucidating the pathogenesis of neurological diseases.</p><p>With the ongoing advancement of bioinformatics tools and research, a variety of biological signal pathway databases have emerged [<xref rid="R2" ref-type="bibr">2</xref>]. These databases store biological entities and their interactions, aiding researchers in obtaining and analyzing the necessary data. In addition to official institutions focusing on the construction of biological databases, there are also bioinformatics laboratories and biological companies as profit-making organizations that carry out relevant construction. According to different research fields, databases with different focuses have been established, such as cell signaling pathway databases for different species, or specialized signaling pathway databases for signal transduction pathways related to a certain protein family. These biosignaling pathway databases come in different forms, including commercial databases such as Elsevier EmBiology, a platform for exploring biological pathways [<xref rid="R3" ref-type="bibr">3</xref>], and QIAGEN Ingenuity Pathway Analysis, a tool for the analysis and visualization of biological pathways and networks [<xref rid="R4" ref-type="bibr">4</xref>], which provide high-quality data and robust analytical tools, catering to researchers with demanding precision and integration needs. On the other hand, noncommercial databases like KEGG [<xref rid="R5" ref-type="bibr">5</xref>], which contain data written by biologists and reviewed by professionals, and open platforms like WikiPathways [<xref rid="R6" ref-type="bibr">6</xref>], which allow users to upload, maintain, and discuss biosignaling pathway data, offer valuable resources to the scientific community. Most databases will give relevant information of each node in the biological signaling pathway network, such as entity name and related genes, directly or through linkage with other databases. Additionally, there are databases like STRING, which focuses on known and predicted protein&#x02013;protein interactions [<xref rid="R7" ref-type="bibr">7</xref>], and ANDSystem, a tool for automatic knowledge extraction and reconstruction of associative gene networks [<xref rid="R8" ref-type="bibr">8</xref>], which provide valuable resources for researchers studying biological pathways and their broader connections to molecular networks.</p><p>Despite the availability of numerous biological signal pathway databases, many of these resources suffer from certain limitations. The existing databases often attach most of its focus on the entities in the signaling pathway and derive various biological informations based on them. However, the interactions between entities also play an important role in the process of biological signal transduction, which is often neglected when signal pathways are mentioned and analyzed. The classification of the pathways usually accord to the biological function of them, leading to the neglection of the character of the signal transduction pathway itself, which may bring new perspectives and new opportunities for the development of system biology research and precision medicine in the era of &#x0201c;biological big data.&#x0201d; In addition, the representation of signal pathways lacks a unified format, which makes it difficult for researchers to effectively represent these pathways and utilize various downstream analysis tools.</p><p>To address these limitations, we present STCDB4ND (<ext-link xlink:href="https://bis.zju.edu.cn/STCDB" ext-link-type="uri">https://bis.zju.edu.cn/STCDB</ext-link>), a user-friendly biological signaling transduction pathway database for neurological diseases. This database employs the ST classification system [<xref rid="R9" ref-type="bibr">9</xref>] to store and display biological signaling pathways, incorporating the interactions within these pathways. This approach provides a standardized format for representing biosignal pathways and emphasizes the characteristics of the pathways themselves. STCDB4ND is integrated with visualization functions and downstream tools for network analysis, offering a convenient resource for researchers seeking to understand biological signaling transduction pathways related to neurological diseases. By setting a new standard for the representation of these pathways, our database provides researchers with a novel perspective for conducting in-depth research in this field.</p></sec><sec id="s2"><title>Materials and methods</title><sec id="s2-s1"><title>ST classification system</title><p>The ST classification system [<xref rid="R9" ref-type="bibr">9</xref>] assigns a unique four-level code, the ST code, to each entity in the cell signal transduction pathway, similar to the enzyme classification system [<xref rid="R10" ref-type="bibr">10</xref>] used by the International Committee on Enzymology. This system allows the interactions between different entities in the pathway to be expressed unambiguously. By converting a signal transduction pathway into a coded string through the ST codes of the interactions, researchers can perform comparison and query operations more easily, facilitating better study of cell signal transduction pathways.</p><p>
<bold>The coding rules for the ST classification system are as follows</bold>:</p><list list-type="bullet"><list-item><p>The first digit in the ST code indicates the occurrence of the action relative to the position of the cell.</p></list-item><list-item><p>The second digit indicates the type of action.</p></list-item><list-item><p>The third digit combines the characteristics of the two entities involved in the action to further specify the action type.</p></list-item><list-item><p>The fourth digit identifies the serial number of the action within the same type.</p></list-item></list><p>
<bold>The specific classifications are shown in</bold> &#x000a0;<xref rid="T1" ref-type="table">Table&#x000a0;1</xref>.</p><table-wrap position="float" id="T1"><label>Table&#x000a0;1.</label><caption><p>Specific classifications of the first two numbers of ST code</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">ST code</th><th align="left" rowspan="1" colspan="1">Character of interaction</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1.*.*.*</td><td align="left" rowspan="1" colspan="1">Extracellular signal reception events</td></tr><tr><td align="left" rowspan="1" colspan="1">1.1.*.*</td><td align="left" rowspan="1" colspan="1">Physical stimulation of receptors</td></tr><tr><td align="left" rowspan="1" colspan="1">1.2.*.*</td><td align="left" rowspan="1" colspan="1">Binding with hormones</td></tr><tr><td align="left" rowspan="1" colspan="1">1.3.*.*</td><td align="left" rowspan="1" colspan="1">Binding with non&#x02010;growth factor cytokines</td></tr><tr><td align="left" rowspan="1" colspan="1">1.4.*.*</td><td align="left" rowspan="1" colspan="1">Binding with growth factors</td></tr><tr><td align="left" rowspan="1" colspan="1">1.5.*.*</td><td align="left" rowspan="1" colspan="1">Binding with neuronal receptors</td></tr><tr><td align="left" rowspan="1" colspan="1">1.6.*.*</td><td align="left" rowspan="1" colspan="1">Binding with other ligands</td></tr><tr><td align="left" rowspan="1" colspan="1">2.*.*.*</td><td align="left" rowspan="1" colspan="1">Plasma membrane transduction events</td></tr><tr><td align="left" rowspan="1" colspan="1">2.1.*.*</td><td align="left" rowspan="1" colspan="1">Channel operation</td></tr><tr><td align="left" rowspan="1" colspan="1">2.2.*.*</td><td align="left" rowspan="1" colspan="1">Ion channel transduction</td></tr><tr><td align="left" rowspan="1" colspan="1">2.3.*.*</td><td align="left" rowspan="1" colspan="1">G&#x02010;protein transduction</td></tr><tr><td align="left" rowspan="1" colspan="1">2.4.*.*</td><td align="left" rowspan="1" colspan="1">Other Ser/Thr phosphorylation</td></tr><tr><td align="left" rowspan="1" colspan="1">2.5.*.*</td><td align="left" rowspan="1" colspan="1">Tyr phosphorylation</td></tr><tr><td align="left" rowspan="1" colspan="1">2.6.*.*</td><td align="left" rowspan="1" colspan="1">Cleavage</td></tr><tr><td align="left" rowspan="1" colspan="1">2.7.*.*</td><td align="left" rowspan="1" colspan="1">Others</td></tr><tr><td align="left" rowspan="1" colspan="1">3.*.*.*</td><td align="left" rowspan="1" colspan="1">Plasma membrane to cytoplasm transduction events</td></tr><tr><td align="left" rowspan="1" colspan="1">3.1.*.*</td><td align="left" rowspan="1" colspan="1">Membrane receptor releasing</td></tr><tr><td align="left" rowspan="1" colspan="1">3.2.*.*</td><td align="left" rowspan="1" colspan="1">Protein&#x02013;protein interaction</td></tr><tr><td align="left" rowspan="1" colspan="1">4.*.*.*</td><td align="left" rowspan="1" colspan="1">Intracellular signal transduction events</td></tr><tr><td align="left" rowspan="1" colspan="1">4.1.*.*</td><td align="left" rowspan="1" colspan="1">Ser/Thr phosphorylation</td></tr><tr><td align="left" rowspan="1" colspan="1">4.2.*.*</td><td align="left" rowspan="1" colspan="1">Tyr phosphorylation</td></tr><tr><td align="left" rowspan="1" colspan="1">4.3.*.*</td><td align="left" rowspan="1" colspan="1">Other phosphorylation</td></tr><tr><td align="left" rowspan="1" colspan="1">4.4.*.*</td><td align="left" rowspan="1" colspan="1">Dephosphorylation</td></tr><tr><td align="left" rowspan="1" colspan="1">4.5.*.*</td><td align="left" rowspan="1" colspan="1">Ubiquitination</td></tr><tr><td align="left" rowspan="1" colspan="1">4.6.*.*</td><td align="left" rowspan="1" colspan="1">Methylation</td></tr><tr><td align="left" rowspan="1" colspan="1">4.7.*.*</td><td align="left" rowspan="1" colspan="1">Deamination</td></tr><tr><td align="left" rowspan="1" colspan="1">4.8.*.*</td><td align="left" rowspan="1" colspan="1">Nitrosylation</td></tr><tr><td align="left" rowspan="1" colspan="1">4.9.*.*</td><td align="left" rowspan="1" colspan="1">GDP/GTP conversion</td></tr><tr><td align="left" rowspan="1" colspan="1">4.10.*.*</td><td align="left" rowspan="1" colspan="1">Dimerization</td></tr><tr><td align="left" rowspan="1" colspan="1">4.11.*.*</td><td align="left" rowspan="1" colspan="1">Protein&#x02013;protein interaction</td></tr><tr><td align="left" rowspan="1" colspan="1">4.12.*.*</td><td align="left" rowspan="1" colspan="1">Others</td></tr><tr><td align="left" rowspan="1" colspan="1">5.*.*.*</td><td align="left" rowspan="1" colspan="1">Cytoplasm to nucleoplasm transduction events</td></tr><tr><td align="left" rowspan="1" colspan="1">5.1.*.*</td><td align="left" rowspan="1" colspan="1">Others</td></tr><tr><td align="left" rowspan="1" colspan="1">6.*.*.*</td><td align="left" rowspan="1" colspan="1">Nucleoplasm to nucleoplasm transduction events</td></tr><tr><td align="left" rowspan="1" colspan="1">6.1.*.*</td><td align="left" rowspan="1" colspan="1">Binding with nuclear receptor</td></tr><tr><td align="left" rowspan="1" colspan="1">6.2.*.*</td><td align="left" rowspan="1" colspan="1">Binding with transcription factor</td></tr><tr><td align="left" rowspan="1" colspan="1">6.3.*.*</td><td align="left" rowspan="1" colspan="1">Acetylation</td></tr><tr><td align="left" rowspan="1" colspan="1">6.4.*.*</td><td align="left" rowspan="1" colspan="1">Deacetylation</td></tr><tr><td align="left" rowspan="1" colspan="1">6.5.*.*</td><td align="left" rowspan="1" colspan="1">Others</td></tr></tbody></table></table-wrap></sec><sec id="s2-s2"><title>Data source</title><p>Data in this database were manually collected from several authoritative databases such as KEGG [<xref rid="R5" ref-type="bibr">5</xref>] and Reactome [<xref rid="R11" ref-type="bibr">11</xref>]. Each interaction was assigned a unique ST number according to the ST classification system. Protein and small molecule compound data were sourced from Uniprot [<xref rid="R12" ref-type="bibr">12</xref>] and CHEMBL [<xref rid="R13" ref-type="bibr">13</xref>]. The current database integrates 169 biological signal transduction pathways related to neurological diseases, involving 288 entities and 277 interactions. The selection of these pathways was based on a comprehensive review of multiple pathway databases, including KEGG and Reactome, with a focus on pathways that have reliable literature references.</p></sec><sec id="s2-s3"><title>Alignment algorithm</title><p>The basic idea behind comparing two signal transduction pathways in the ST system is similar to the Smith&#x02013;Waterman algorithm [<xref rid="R14" ref-type="bibr">14</xref>], modified to fit the characteristics of signal pathways. The replacement matrix in our alignment algorithm is generated based on the similarities of the ST numbers in the sequence. The similarity <inline-formula id="ILM0001"><tex-math notation="LaTeX" id="ILM0001-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$\sigma \left( {\alpha ,\beta } \right)$\end{document}</tex-math></inline-formula> of the two pathways <inline-formula id="ILM0002"><tex-math notation="LaTeX" id="ILM0002-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$\alpha \left( {{a_1},{a_2},{a_3},{a_4}} \right)$\end{document}</tex-math></inline-formula>, <inline-formula id="ILM0003"><tex-math notation="LaTeX" id="ILM0003-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$\beta \left( {{b_1},{b_2},{b_3},{b_4}} \right)$\end{document}</tex-math></inline-formula> is determined by the following rule:</p><disp-formula id="M0001">
<label>(1)</label>
<tex-math notation="LaTeX" id="M0001-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$\sigma \left( {\alpha ,\beta } \right) = \left\{ \begin{array}{l}
0,\,{\mathrm{ }}while\,{\mathrm{ a}}1 \ne {\mathrm{b}}1\\
0.25,\,{\mathrm{ }}while\,{\mathrm{ a}}1 = {\mathrm{b}}1\&#x00026; {\mathrm{a2}} \ne {\mathrm{b2}}\\
{\mathrm{0}}{\mathrm{.5,\, }}while\,{\mathrm{ a1}} = {\mathrm{b1}}\&#x00026; {\mathrm{a2}} = {\mathrm{b2}}\&#x00026; {\mathrm{a3}} \ne {\mathrm{b3}}\\
{\mathrm{0}}{\mathrm{.75,\, }}while\,{\mathrm{ a1}} = {\mathrm{b1}}\&#x00026; {\mathrm{a2}} = {\mathrm{b2}}\&#x00026; {\mathrm{a3}} = {\mathrm{b3}}\&#x00026; {\mathrm{a4}} \ne {\mathrm{b4}}\\
{\mathrm{1}},\,{\mathrm{ }}while\,{\mathrm{ a1}} = {\mathrm{b1}}\&#x00026; {\mathrm{a2}} = {\mathrm{b2}}\&#x00026; {\mathrm{a3}} = {\mathrm{b3}}\&#x00026; {\mathrm{a4}} = {\mathrm{b4}}
\end{array} \right.$$\end{document}</tex-math>
</disp-formula><p>
where the gap penalty is set to 0. The similarity score is the maximum matching score of the two pathways, divided by the length of the longer pathway. For pathways <inline-formula id="ILM0004"><tex-math notation="LaTeX" id="ILM0004-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$PW1:\left\{ {{\alpha _i}} \right\}$\end{document}</tex-math></inline-formula> and <inline-formula id="ILM0005"><tex-math notation="LaTeX" id="ILM0005-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$PW2:\left\{ {{\beta _i}} \right\}$\end{document}</tex-math></inline-formula>, with lengths L1 and L2 respectively, the similarity <inline-formula id="ILM0006"><tex-math notation="LaTeX" id="ILM0006-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$f\left( {PW1,PW2} \right)$\end{document}</tex-math></inline-formula> is given by:</p><disp-formula id="M0002">
<label>(2)</label>
<tex-math notation="LaTeX" id="M0002-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$f({\mathrm{PW}}1,{\mathrm{PW}}2) = \frac{{\max \left( {\sum\limits_{{\mathrm{i}} = {\mathrm{1}}}^{{\mathrm{L1}}} {\sigma \left( {\alpha i{\mathrm{ or }}\varepsilon ,\beta j{\mathrm{ or }}\varepsilon } \right)} } \right)}}{{{\mathrm{max(L1,L2)}}}}$$\end{document}</tex-math>
</disp-formula><p>
<bold>Where &#x003b5; represents the operation to insert a gap element</bold>.</p></sec><sec id="s2-s4"><title>Key node analysis</title><p>To identify key factors in the directed weighted network of cell signal transduction pathways, we referred to the DWNodeRank algorithm [<xref rid="R15" ref-type="bibr">15</xref>], which is based on the PageRank algorithm [<xref rid="R16" ref-type="bibr">16</xref>]. This algorithm allocates PageRank values according to node weight during transductions, thus introducing the influence of weight in analyzing the key nodes of the network. The element <italic toggle="yes">m<sub>ij</sub></italic> in the transition matrix M is given by:</p><disp-formula id="M0003">
<label>(3)</label>
<tex-math notation="LaTeX" id="M0003-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$${{\mathrm{m}}_{{\mathrm{ij}}}} = \frac{{{w_{ij}}}}{{\sum\limits_{{v_k} \in M\left( {{v_i}} \right)} {{w_{ik}}} }}$$\end{document}</tex-math>
</disp-formula><p>
where <inline-formula id="ILM0007"><tex-math notation="LaTeX" id="ILM0007-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
${w_{ij}}$\end{document}</tex-math></inline-formula> is the weight value of the edge from node <italic toggle="yes">j</italic> to node <italic toggle="yes">i</italic>. The importance value <inline-formula id="ILM0008"><tex-math notation="LaTeX" id="ILM0008-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$NR\left( {{v_i}} \right)$\end{document}</tex-math></inline-formula> of node <inline-formula id="ILM0009"><tex-math notation="LaTeX" id="ILM0009-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
${v_i}$\end{document}</tex-math></inline-formula> is then calculated as:</p><disp-formula id="M0004">
<label>(4)</label>
<tex-math notation="LaTeX" id="M0004-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$NR\left( {{v_i}} \right) = d\sum\limits_{{v_j} \in M\left( {{v_i}} \right)} {\frac{{{w_{ij}}}}{{\sum\limits_{{v_k} \in M\left( {{v_i}} \right)} {{w_{ik}}} }}} NR\left( {{v_j}} \right) + \frac{{1 - d}}{n}$$\end{document}</tex-math>
</disp-formula><p>The key node analysis tool in our system uses this method to calculate the NR values of each node in the biosignaling pathway network and sorts these values from high to low to generate key factor recognition results. The algorithm flow is as shown in <xref rid="F1" ref-type="fig">Fig.&#x000a0;1</xref>:</p><fig position="float" id="F1" fig-type="figure"><label>Figure&#x000a0;1.</label><caption><p>The flowchart of the key factor recognition algorithm, in which M is the transition matrix, R refers to the vector of node-ranks, <italic toggle="yes">d</italic> is damping factor, and &#x003b5; is the iteration accuracy.</p></caption><graphic xlink:href="baaf032f1" position="float"/></fig><p>Where <inline-formula id="ILM0010"><tex-math notation="LaTeX" id="ILM0010-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
${\mathrm{R}} = \left[ {\begin{array}{*{20}{c}}
{{\mathrm{NR(}}{{\mathrm{v}}_{\mathrm{1}}})}\\
{{\mathrm{NR(}}{{\mathrm{v}}_{\mathrm{2}}})}\\
{\ldots}\\
{{\mathrm{NR(}}{{\mathrm{v}}_{\mathrm{n}}})}
\end{array}} \right]$\end{document}</tex-math></inline-formula>. The damping factor is set to <italic toggle="yes">d</italic>&#x02009;=&#x02009;0.85 and iteration accuracy is set to &#x003b5;&#x02009;=&#x02009;1e-8 in STCDB system.</p></sec><sec id="s2-s5"><title>Database construction</title><p>STCDB system is accessible for noncommercial use through the website. The server runs on the Linux system Ubuntu 20.04. The frontend was built using Bootstrap4.6 (<ext-link xlink:href="https://v4.bootcss.com/" ext-link-type="uri">https://v4.bootcss.com/</ext-link>). The visualization was supported by EChart.js (<ext-link xlink:href="https://echarts.apache.org/zh/index.html" ext-link-type="uri">https://echarts.apache.org/zh/index.html</ext-link>). The backend was supported by Flask2.3.2 (<ext-link xlink:href="https://flask.palletsprojects.com/en/3.0.x/" ext-link-type="uri">https://flask.palletsprojects.com/en/3.0.x/</ext-link>) and Gunicorn22.0.0 (<ext-link xlink:href="https://gunicorn.org/" ext-link-type="uri">https://gunicorn.org/</ext-link>). The MySQL8.0.31 database server was implemented for storing and managing all kinds of pathway data (<xref rid="F2" ref-type="fig">Fig.&#x000a0;2</xref>).</p><fig position="float" id="F2" fig-type="figure"><label>Figure&#x000a0;2.</label><caption><p>Schematic diagram of the data processing and database structure of STCDB4ND in this study.</p></caption><graphic xlink:href="baaf032f2" position="float"/></fig></sec></sec><sec id="s3"><title>Usage and functions</title><sec id="s3-s1"><title>Search</title><p>Our database facilitates a flexible and expedient search system that allows users to retrieve biological signaling pathway-related data based on different ranges (<xref rid="F3" ref-type="fig">Fig.&#x000a0;3A</xref>). Users could easily find the search interface on the homepage. The search interface is easily accessible from the homepage. STCDB provides three search modes: entity mode, entity interaction mode, and cell signal transduction pathway mode, each corresponding to distinct sub-database contents. The entity interaction and cell signal transduction pathway modes support search strategies based on both entity name and ST code. Users can access detailed pages for each entry via hyperlinks on the result page (<xref rid="F3 F3" ref-type="fig">Fig.&#x000a0;3B, C</xref>).</p><fig position="float" id="F3" fig-type="figure"><label>Figure&#x000a0;3.</label><caption><p>Usage pages in STCDB.</p></caption><graphic xlink:href="baaf032f3" position="float"/></fig></sec><sec id="s3-s2"><title>Alignment</title><p>The alignment function supports two modes of operation. Users can align the pathway of interest with other signaling pathways in the database, while we also allow users align the pathway of interest with other customized pathways by the user using our alignment page as long as the interactions in the customized pathways are available in our sub database of interactions (<xref rid="F3" ref-type="fig">Fig.&#x000a0;3D</xref>). The pathways can be inputted in the form of either entity strings or ST code strings, using commas as separation. The comparison result page will display the results of each pathway in order of similarity score from high to low (<xref rid="F3" ref-type="fig">Fig.&#x000a0;3E</xref>). The highest similarity score is 1, which indicates that this pathway is the same one as the pathway of interest.</p></sec><sec id="s3-s3"><title>Visualization of multiple pathway networks</title><p>For research involving multiple signaling pathways, the system provides users with the function of pathway network visualization. In the interface of both alignment results and search result page for pathways, users can check the pathways they are interested in and generate the network visualization result of the selected data (<xref rid="F3 F3" ref-type="fig">Fig.&#x000a0;3E, F</xref>). All the entities and interactions are marked with their identification in the network page. The interactions are painted with different colors according to the first digit of its ST number to distinguish the interactions occurred in different relevant positions of the cell (<xref rid="F3" ref-type="fig">Fig.&#x000a0;3G</xref>). Users can interact with the network with their mouse to organize the nodes and lines. It is also available to download the network as still pictures for further research.</p></sec><sec id="s3-s4"><title>Keynode analysis</title><p>To facilitate the analysis of pathway networks, STCDB integrates a key factor analysis tool into the network visualization interface. Users can conveniently identify and analyze key nodes within the network on the same page (<xref rid="F3" ref-type="fig">Fig.&#x000a0;3G</xref>).</p></sec></sec><sec id="s4"><title>Results</title><sec id="s4-s1"><title>Whole map of the neuro-disease-related signal pathways</title><p>We use STCDB to generate a visualized network of all the 169 neurological disease related cell signaling pathways in the system database. The result is as <xref rid="F4" ref-type="fig">Fig.&#x000a0;4A</xref>.</p><fig position="float" id="F4" fig-type="figure"><label>Figure&#x000a0;4.</label><caption><p>The whole map of the the network of neurological diseases related cell signaling transduction pathways, and figures of heatmap generated from disease data collected from DiSignAtlas website and the PPI network of TUBA4A from NDAtlas website.</p></caption><graphic xlink:href="baaf032f4" position="float"/></fig></sec><sec id="s4-s2"><title>Key nodes of the neurological disease-related signal pathway network</title><p>Using the key factor identification tool of this system to calculate the key factors of the network, the result of top 5 key factors are CYCS, APAF1,CASP9, Ca<sup>2+</sup>,TUBA.</p><p>CYCS, APAF1, and CASP9 are important signaling factor in the process of inducing cell apoptosis. This result indicates that in pathways related to neurological diseases, many pathogenic factors ultimately lead to disease by causing abnormal mitochondrial pathway-mediated apoptosis. This finding is consistent with previous research results [<xref rid="R17" ref-type="bibr">17</xref>] . We attached transcriptomic data of several neurological diseases collected from DiSignAtlas (<ext-link xlink:href="http://www.inbirg.com/disignatlas/" ext-link-type="uri">http://www.inbirg.com/disignatlas/</ext-link>) to show the differential expression of the related genes [<xref rid="R18" ref-type="bibr">18</xref>], and the result is as <xref rid="F4" ref-type="fig">Fig.&#x000a0;4B</xref> that related genes were differentially expressed in multiple datasets (<xref rid="F4" ref-type="fig">Fig.&#x000a0;4B</xref>). The result with high confidence of the CYCS and CASP9 protein from NDAtlas (<ext-link xlink:href="https://bis.zju.edu.cn/ndatlas/" ext-link-type="uri">https://bis.zju.edu.cn/ndatlas/</ext-link>) [<xref rid="R19" ref-type="bibr">19</xref>] also shows that these related entities play important roles in neurodegenerative diseases (<xref rid="s7" ref-type="sec">Supplementary Table&#x000a0;1</xref>.).</p><p>Ca<sup>2+</sup> (calcium ion) plays a crucial role in the neurological system, being involved in neurotransmission, signal transduction, and apoptosis. Dysregulation of calcium ions is closely associated with many neurological diseases. Targeting calcium homeostasis presents a promising therapeutic strategy. Calcium channel blockers, calmodulin inhibitors, and drugs regulating calcium homeostasis have shown potential in treating these diseases [<xref rid="R20" ref-type="bibr">20</xref>]. Therefore, further research into calcium regulation could lead to novel and effective treatments for various neurodegenerative and neurological disorders, highlighting the critical role of calcium ions in both the pathogenesis and potential therapy of these conditions.</p><p>TUBA is a major constituent of microtubules, playing a vital role in cell structure and function. Many neurological diseases are associated with microtubules. According to previous research, damage to microtubules in neuronal axons can lead to the accumulation of pathological proteins, resulting in severe dysfunction of certain neurons. Additionally, there is a correlation between abnormal neuronal activity and changes in microtubule homeostasis, suggesting that alterations in microtubule stability may be a critical factor in the development of neurodegenerative diseases. Microtubule stabilizers have been used to treat chronic neurodegenerative diseases and to intervene in malignant neurological conditions, such as brain tumors [<xref rid="R21" ref-type="bibr">21</xref>]. Our identification results provide theoretical support for further research in this direction, reinforcing the belief that microtubule-related studies could be a promising new avenue for the treatment of neurological diseases. We also attached transcriptomic data of several neurological diseases collected from DiSignAtlas [<xref rid="R18" ref-type="bibr">18</xref>] to show the differential expression of TUBA-related genes, and the result is as <xref rid="F4" ref-type="fig">Fig.&#x000a0;4C</xref> that related genes were differentially expressed in multiple datasets (<xref rid="F4" ref-type="fig">Fig.&#x000a0;4C</xref>), among which TUBA4A shows the biggest difference comparing with the control group. The PPI network of TUBA4A [<xref rid="R19" ref-type="bibr">19</xref>] involves a wide variety of proteins functioning in multiple biological functional processes, reflecting its importance (<xref rid="F4" ref-type="fig">Fig.&#x000a0;4D</xref>).</p></sec></sec><sec id="s5"><title>Discussion and conclusions</title><p>The STCDB4ND database was developed to address critical gaps in the representation and analysis of signal transduction pathways related to neurological diseases. By leveraging the ST classification system, our database standardizes the depiction of these pathways, emphasizing both entity interactions and pathway-specific characteristics. This unified framework enhances the interpretability and comparability of pathways, providing a solid foundation for advanced analyses.</p><p>STCDB4ND offers functionalities beyond basic data retrieval, including pathway alignment, multi-pathway visualization, and key factor identification. The alignment feature allows researchers to compare pathways systematically, uncovering similarities and differences that may yield new insights into disease mechanisms Multi-pathway visualization facilitates the exploration of complex networks, reflecting the simultaneous biological activities occurring <italic toggle="yes">in vivo</italic>. Additionally, the key factor analysis tool identifies critical nodes within signaling networks, streamlining the identification of potential therapeutic targets.</p><p>Using STCDB4ND, we visualized a comprehensive network of neurological disease-related pathways and identified key signaling factors such as CYCS, APAF1, and CASP9, which are integral to mitochondrial apoptosis pathways. These findings corroborate existing research and highlight the significance of dysregulated apoptosis in the pathogenesis of neurological diseases. The identification of calcium ions (Ca<sup>2+</sup>) and TUBA-related factors further underscores their roles in neural signal transduction and cytoskeletal dynamics, offering promising directions for future research and therapeutic development.</p><p>Currently, the STCDB system integrates only cell signal transduction pathways related to human neurological diseases. However, we believe the STCDB system is also applicable to other species and types of cell signal transduction pathways. We aim to expand the STCDB system&#x02019;s database in the future, incorporating more data to provide greater convenience for researchers in various fields.</p><p>To ensure the database remains up-to-date and relevant, we plan to establish a regular update mechanism, conducting comprehensive updates every year. These updates will integrate findings from major biological pathway databases and the latest literature, allowing the inclusion of cutting-edge research discoveries. Additionally, we aim to expand the database over the next five years to include neurological disease-related pathways for more model organisms, such as <italic toggle="yes">Caenorhabditis elegans</italic>, zebrafish, and mice. This will enable researchers to compare differences between various model organisms and humans more effectively.</p><p>In the future, we also plan to develop different versions of the database tailored to specific disease types, creating dedicated resources for various categories of diseases. These efforts will significantly enhance the utility and applicability of the STCDB system for researchers in diverse fields.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="sup1" position="float" content-type="local-data"><label>baaf032_Supp</label><media xlink:href="baaf032_supp.zip"/></supplementary-material></sec></body><back><ack id="ack1"><title>Acknowledgements</title><p>The authors are grateful to the members of Ming Chen&#x02019;s laboratory for helpful discussions and valuable comments.</p></ack><sec id="s6"><title>Author contributions</title><p>M.C. and R.H. conceived the idea for this research project. B.G. executed the data collection process and constructed the database, designed and developed the web page and visual modules, and implemented the algorithms of the functions in the website. S. L. was responsible for the deployment of the server, ensuring the project&#x02019;s availability to users. Y.F. made suggestions on the design of the website page. All authors contributed to the writing and revision of the manuscript.</p></sec><sec id="s7"><title>Supplementary data</title><p>
<xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> is available at <italic toggle="yes">Database</italic> online.</p></sec><sec sec-type="COI-statement" id="s8"><title>Conflict of interest:</title><p>None declared.</p></sec><sec id="s9"><title>Funding</title><p>This work was supported by the SRTP Program of Zhejiang University [Y202304085] and the student innovation research program of Zhejiang University Qiushi Class (Biological Sciences), and partially supported by the National Key Research and Development Program of China [2023YFE0112300]; the Science and Technology Innovation Leading Scientist [2022R52035], the 151 talent project of Zhejiang Province (first level); and Collaborative Innovation Center for Modern Crop Production co-sponsored by province and ministry.</p></sec><sec sec-type="data-availability" id="s10"><title>Data availability</title><p>The data can be accessed from the databases module of the website.</p></sec><ref-list id="ref1"><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Li</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>L</given-names></string-name></person-group> &#x000a0;<article-title>Therapeutic potential of natural compounds from herbs and nutraceuticals in alleviating neurological disorders: targeting the wnt signaling pathway</article-title>. <source><italic toggle="yes">J Agr Food Chem</italic></source> &#x000a0;<year>2024</year>;<volume>72</volume>:<fpage>2411</fpage>&#x02013;<lpage>33</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acs.jafc.3c07536</pub-id><pub-id pub-id-type="pmid">38284360</pub-id>
</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chowdhury</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Sarkar</surname> &#x000a0;<given-names>RR</given-names></string-name></person-group> &#x000a0;<article-title>Comparison of human cell signaling pathway databases&#x02014;evolution, drawbacks and challenges</article-title>. <source><italic toggle="yes">Database</italic></source> &#x000a0;<year>2015</year>;<volume>2015</volume>:<page-range>bau126</page-range>.</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<collab>Elsevier. EmBiology Biological data structured for insights Elsevier [DB/OL]</collab>
</person-group>. (<year>2023</year>). <ext-link xlink:href="https://www.elsevier.com/products/embiology" ext-link-type="uri">https://www.elsevier.com/products/embiology</ext-link> [<comment>2025-01-12</comment>]</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<collab>QIAGEN. Ingenuity Pathway Analysis QIAGEN Digital Insights [DB/OL]</collab>
</person-group>. (<year>2023</year>). <ext-link xlink:href="https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-ipa/" ext-link-type="uri">https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-ipa/</ext-link> [<comment>2025-02-12</comment>]</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kanehisa</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Furumichi</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Sato</surname> &#x000a0;<given-names>Y</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>KEGG: integrating viruses and cellular organisms</article-title>. <source><italic toggle="yes">Nucleic Acids Res</italic></source> &#x000a0;<year>2021</year>;<volume>49</volume>:<fpage>D545</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="pmid">33125081</pub-id>
</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Martens</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Ammar</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Riutta</surname> &#x000a0;<given-names>A</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>WikiPathways: connecting communities</article-title>. <source><italic toggle="yes">Nucleic Acids Res</italic></source> &#x000a0;<year>2021</year>;<volume>49</volume>:<fpage>D613</fpage>&#x02013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkaa1024</pub-id><pub-id pub-id-type="pmid">33211851</pub-id>
</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Szklarczyk</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Kirsch</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Koutrouli</surname> &#x000a0;<given-names>M</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>The STRING database in 2023: protein&#x02013;protein association networks and functional enrichment analyses for any sequenced genome of interest</article-title>. <source><italic toggle="yes">Nucleic Acids Res</italic></source> &#x000a0;<year>2023</year>;<volume>51</volume>:<fpage>D638</fpage>&#x02013;<lpage>D646</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkac1000</pub-id><pub-id pub-id-type="pmid">36370105</pub-id>
</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>A</surname> &#x000a0;<given-names>IV</given-names></string-name>
</person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>A new version of the ANDSystem tool for automatic extraction of knowledge from scientific publications with expanded functionality for reconstruction of associative gene networks by considering tissue-specific gene expression</article-title>. <source><italic toggle="yes">BMC Bioinf</italic></source> &#x000a0;<year>2019</year>;<volume>20</volume>:<page-range>34</page-range>.</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chen</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Lin</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Hofestaedt</surname> &#x000a0;<given-names>R</given-names></string-name></person-group> &#x000a0;<article-title>STCDB: signal transduction classification database</article-title>. <source><italic toggle="yes">Nucleic Acids Res</italic></source> &#x000a0;<year>2004</year>;<volume>32</volume>:<fpage>D456</fpage>&#x02013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkh079</pub-id><pub-id pub-id-type="pmid">14681456</pub-id>
</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>McDonald</surname> &#x000a0;<given-names>AG</given-names></string-name>, <string-name><surname>Tipton</surname> &#x000a0;<given-names>KF</given-names></string-name></person-group> &#x000a0;<article-title>Enzyme nomenclature and classification: the state of the art</article-title>. <source><italic toggle="yes">Febs J</italic></source> &#x000a0;<year>2023</year>;<volume>290</volume>:<fpage>2214</fpage>&#x02013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1111/febs.16274</pub-id><pub-id pub-id-type="pmid">34773359</pub-id>
</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gillespie</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Jassal</surname> &#x000a0;<given-names>B</given-names></string-name>, <string-name><surname>Stephan</surname> &#x000a0;<given-names>R</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>The reactome pathway knowledgebase 2022</article-title>. <source><italic toggle="yes">Nucleic Acids Res</italic></source> &#x000a0;<year>2022</year>;<volume>50</volume>:<fpage>D687</fpage>&#x02013;<lpage>92</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkab1028</pub-id><pub-id pub-id-type="pmid">34788843</pub-id>
</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bateman</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Martin</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Orchard</surname> &#x000a0;<given-names>S</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>UniProt: the universal protein knowledgebase in 2023</article-title>. <source><italic toggle="yes">Nucleic Acids Res</italic></source> &#x000a0;<year>2023</year>;<volume>51</volume>:<fpage>D523</fpage>&#x02013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkac1052</pub-id><pub-id pub-id-type="pmid">36408920</pub-id>
</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mendez</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Gaulton</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Bento</surname> &#x000a0;<given-names>AP</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>ChEMBL: towards direct deposition of bioassay data</article-title>. <source><italic toggle="yes">Nucleic Acids Res</italic></source> &#x000a0;<year>2019</year>;<volume>47</volume>:<fpage>D930</fpage>&#x02013;<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gky1075</pub-id><pub-id pub-id-type="pmid">30398643</pub-id>
</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Smith</surname> &#x000a0;<given-names>TF</given-names></string-name>, <string-name><surname>Waterman</surname> &#x000a0;<given-names>MS</given-names></string-name></person-group> &#x000a0;<article-title>Identification of common molecular subsequences</article-title>. <source><italic toggle="yes">J Mol Biol</italic></source> &#x000a0;<year>1981</year>;<volume>147</volume>:<fpage>195</fpage>&#x02013;<lpage>97</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0022-2836(81)90087-5</pub-id><pub-id pub-id-type="pmid">7265238</pub-id>
</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Hu</surname> &#x000a0;<given-names>M</given-names></string-name>
</person-group> &#x000a0;<source><italic toggle="yes">Research on Key Node Identification Technology of Directed Weighted Complex Network Based on Link Relationship [Master]</italic></source>. <publisher-loc>Nanjing, Jiangsu, China</publisher-loc>: <publisher-name>Nanjing University of Science and Technology</publisher-name>, <year>2012</year>.</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Brin</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Page</surname> &#x000a0;<given-names>L</given-names></string-name></person-group> &#x000a0;<article-title>The anatomy of a large-scale hypertextual web search engine</article-title>. <source><italic toggle="yes">Computer Networks and ISDN Systems</italic></source> &#x000a0;<year>1998</year>;<volume>30</volume>:<fpage>107</fpage>&#x02013;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0169-7552(98)00110-X</pub-id></mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Satoh</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Kawana</surname> &#x000a0;<given-names>N</given-names></string-name>, <string-name><surname>Yamamoto</surname> &#x000a0;<given-names>Y</given-names></string-name></person-group> &#x000a0;<article-title>Pathway analysis of ChIP-Seq-based NRF1 target genes suggests a logical hypothesis of their involvement in the pathogenesis of neurodegenerative diseases</article-title>. <source><italic toggle="yes">Gene Regulation and Systems Biology</italic></source> &#x000a0;<year>2013</year>;<volume>7</volume>:<page-range>GRSB.S13204</page-range>.</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhai</surname> &#x000a0;<given-names>Z</given-names></string-name>, <string-name><surname>Lin</surname> &#x000a0;<given-names>Z</given-names></string-name>, <string-name><surname>Meng</surname> &#x000a0;<given-names>X</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>DiSignAtlas: an atlas of human and mouse disease signatures based on bulk and single-cell transcriptomics[J]</article-title>. <source><italic toggle="yes">Nucleic Acids Res</italic></source> &#x000a0;<year>2024</year>;<volume>52</volume>:<fpage>D1236</fpage>&#x02013;<lpage>D1245</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkad961</pub-id><pub-id pub-id-type="pmid">37930831</pub-id>
</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chen</surname> &#x000a0;<given-names>H</given-names></string-name>, <string-name><surname>Zhou</surname> &#x000a0;<given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>Y</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Network integration and protein structural binding analysis of neurodegeneration-related interactome</article-title>. <source><italic toggle="yes">Brief Bioinform</italic></source> &#x000a0;<year>2023</year>;<volume>24</volume>:<page-range>bbad237</page-range>. doi: <pub-id pub-id-type="doi">10.1093/bib/bbad237</pub-id></mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Antunes</surname> &#x000a0;<given-names>FTT</given-names></string-name>, <string-name><surname>De Souza</surname> &#x000a0;<given-names>AH</given-names></string-name>, <string-name><surname>Figueira</surname> &#x000a0;<given-names>J</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>Targeting N-type calcium channels in young-onset of some neurological diseases</article-title>. <source><italic toggle="yes">Front Cell Dev Biol</italic></source> &#x000a0;<year>2022</year>;<volume>10</volume>:<page-range>1090765</page-range>. doi: <pub-id pub-id-type="doi">10.3389/fcell.2022.1090765</pub-id></mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhao</surname> &#x000a0;<given-names>X</given-names></string-name>, <string-name><surname>Zeng</surname> &#x000a0;<given-names>W</given-names></string-name>, <string-name><surname>Xu</surname> &#x000a0;<given-names>H</given-names></string-name></person-group> &#x000a0;<etal>et&#x000a0;al.</etal> &#x000a0;<article-title>A microtubule stabilizer ameliorates protein pathogenesis and neurodegeneration in mouse models of repetitive traumatic brain injury</article-title>. <source><italic toggle="yes">Sci Transl Med</italic></source> &#x000a0;<year>2023</year>;<volume>15</volume>:<page-range>eabo6889</page-range>. doi: <pub-id pub-id-type="doi">10.1126/scitranslmed.abo6889</pub-id></mixed-citation></ref></ref-list></back></article>